Open access
Open access
Powered by Google Translator Translator

Breast Surgery

Artificial intelligence evaluation of 122 969 mammography examinations from a population-based screening program.

30 Mar, 2022 | 08:49h | UTC

Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program – Radiology

News Release: AI shows potential in breast cancer screening programs – Radiological Society of North America

 


Half of all women experience false positive mammograms after 10 years of annual screening.

28 Mar, 2022 | 08:53h | UTC

News Release: Half of all women experience false positive mammograms after 10 years of annual screening – University of California – Davis Health

Original Study: Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography – JAMA Network Open

 

Commentary on Twitter

 


Long-term longitudinal patterns of patient-reported fatigue after breast cancer: a group-based trajectory analysis.

22 Mar, 2022 | 08:29h | UTC

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis – Journal of Clinical Oncology

 

Commentary on Twitter

 


The incidence of breast cancer recurrence 10-32 years after primary diagnosis.

22 Mar, 2022 | 08:12h | UTC

The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis – JNCI: Journal of the National Cancer Institute

 


Study shows low risk of complications after ipsilateral intravenous catheter placement in breast cancer surgery patients.

18 Mar, 2022 | 08:48h | UTC

Ipsilateral Intravenous Catheter Placement in Breast Cancer Surgery Patients – Anesthesia & Analgesia (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Retrospective Cohort Study: Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination.

11 Mar, 2022 | 10:05h | UTC

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Related:

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging.

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

 


RCT: Overall survival with Ribociclib plus Letrozole in advanced breast cancer.

11 Mar, 2022 | 09:47h | UTC

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries:

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer – University of Texas MD Anderson Cancer Center / News Medical

Adding Ribociclib to Letrozole Prolongs Survival in Advanced Breast Cancer – HealthDay

 


Breast cancer risk evaluation for the primary care physician.

10 Mar, 2022 | 10:30h | UTC

Breast cancer risk evaluation for the primary care physician – Cleveland Clinic Journal of Medicine

 


Mapping systematic reviews of breast cancer survivorship interventions.

10 Mar, 2022 | 10:16h | UTC

Mapping Systematic Reviews of Breast Cancer Survivorship Interventions: A Network Analysis – Journal of Clinical Oncology

 

Commentary on Twitter

 


New research finds breast cancer overdiagnosis not as common as previously thought.

7 Mar, 2022 | 00:36h | UTC

Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort – Annals of Internal Medicine (link to abstract – $ for full-text)

How often is breast cancer overdiagnosed? New research finds true cases far outweigh false alarms – STAT

Breast cancer overdiagnosis may not happen as frequently as previously thought – ACP Internist

 


Cancer risks other than female breast and ovarian cancers associated with BRCA1 and BRCA2 pathogenic variants.

3 Mar, 2022 | 08:14h | UTC

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants – Journal of Clinical Oncology

Commentary: Faulty BRCA genes linked to prostate and pancreatic cancers – University of Cambridge

 


RCT: Referral for early, supported exercise after breast cancer surgery improves shoulder function and health-related quality of life.

1 Mar, 2022 | 08:50h | UTC

Abstract: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment

Full Report: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment

Related: RCT: Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema.

 


Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review.

24 Feb, 2022 | 10:11h | UTC

Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review – American Journal of Roentgenology

 


Guideline: Recommendations on Breast Ultrasound – Part I – Examination technique, ultrasound criteria, and documentation.

16 Feb, 2022 | 08:27h | UTC

Best Practice Guideline – DEGUM Recommendations on Breast Ultrasound – Part I – Examination technique, DEGUM ultrasound criteria, and documentation – Ultraschall in der Medizin

 


Aromatase inhibitors vs. tamoxifen in premenopausal women with estrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomized trials

13 Feb, 2022 | 21:32h | UTC

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials – The Lancet Oncology

Commentaries:

Aromatase Inhibitors May Benefit Premenopausal Women With Breast Cancer – HealthDay

Aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in premenopausal as well as postmenopausal women – Cancer Research UK

 


RCT: Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema.

4 Feb, 2022 | 08:35h | UTC

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema: A Randomized Controlled Trial – Journal of Clinical Oncology

 


Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicenter pooled analysis of 5161 patients.

2 Feb, 2022 | 08:22h | UTC

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients – The Lancet Oncology

Commentary: Long-Term Outcomes According to Residual Cancer Burden After Neoadjuvant Chemotherapy for Breast Cancer – The ASCO Post

 


Observational Study: Same-day mastectomy and axillary lymph node dissection seems safe for most patients with breast cancer.

1 Feb, 2022 | 08:38h | UTC

Same-day mastectomy and axillary lymph node dissection is safe for most patients with breast cancer – Journal of Surgical Oncology

 


Outcome of patients with an ultralow-risk 70-gene signature in the MINDACT trial.

24 Jan, 2022 | 08:08h | UTC

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)

Related:

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer – New England Journal of Medicine

 

Commentary on Twitter:

 


Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.

20 Jan, 2022 | 08:57h | UTC

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update – Journal of Clinical Oncology

 

Commentary on Twitter

 


RCT: In premenopausal women with breast cancer, gonadotropin-releasing hormone analogs may preserve ovarian function against chemotherapy-induced gonadotoxic effects.

11 Jan, 2022 | 02:26h | UTC

Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial – JAMA Oncology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


RCT: In patients presenting with metastatic breast cancer, early locoregional therapy for the primary site did not improve survival or quality of life.

11 Jan, 2022 | 02:29h | UTC

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108) – Journal of Clinical Oncology (link to abstract – $ for full-text)

 


Systematic Review: Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer.

9 Dec, 2021 | 10:08h | UTC

Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) – British Journal of Cancer

 

Commentary on Twitter (thread – click for more)

 


RCT: 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer.

2 Dec, 2021 | 09:49h | UTC

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice.

30 Nov, 2021 | 09:55h | UTC

Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice – JCO Oncology Practice

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.